ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 562,06
0,56%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. OptimizeRx Corporation (OPRX)

  7. OptimizeRx Corporation (OPRX) Actualités

OPRX

OptimizeRx (OPRX)

OptimizeRx Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:OPRX
DateHeureSourceTitreSymboleSociété
11/06/202423h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
10/06/202415h00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OPRXOptimizeRx Corporation
07/06/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPRXOptimizeRx Corporation
15/05/202423h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OPRXOptimizeRx Corporation
07/05/202403h34Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:OPRXOptimizeRx Corporation
14/02/202423h05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:OPRXOptimizeRx Corporation
09/01/202422h28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OPRXOptimizeRx Corporation
05/01/202423h19Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:OPRXOptimizeRx Corporation
30/10/202321h06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
20/06/202314h00GlobeNewswire Inc.LifeMD Appoints William J. Febbo to its Board of DirectorsNASDAQ:OPRXOptimizeRx Corporation
09/06/202322h32Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OPRXOptimizeRx Corporation
07/06/202322h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
25/04/202322h29Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OPRXOptimizeRx Corporation
20/04/202321h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPRXOptimizeRx Corporation
10/03/202322h57Edgar (US Regulatory)Annual Report (10-k)NASDAQ:OPRXOptimizeRx Corporation
10/03/202322h53Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:OPRXOptimizeRx Corporation
10/03/202322h47Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:OPRXOptimizeRx Corporation
04/03/202300h56PR Newswire (US)Fair Isaac & Co. Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600NASDAQ:OPRXOptimizeRx Corporation
09/02/202317h53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OPRXOptimizeRx Corporation
11/11/202202h49TipRanksOptimizeRx (OPRX) Receives a Buy from RBC CapitalNASDAQ:OPRXOptimizeRx Corporation
10/11/202205h30TipRanksAnalysts Offer Insights on Technology Companies: Activision Blizzard (ATVI), OptimizeRx (OPRX) and Embark Technology, Inc. (EMBK)NASDAQ:OPRXOptimizeRx Corporation
09/11/202216h25TipRanksOptimizeRx (OPRX) Gets a Buy from B.Riley FinancialNASDAQ:OPRXOptimizeRx Corporation
08/11/202222h46Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OPRXOptimizeRx Corporation
03/10/202220h59Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OPRXOptimizeRx Corporation
15/09/202203h46TipRanksRBC Capital Keeps Their Buy Rating on OptimizeRx (OPRX)NASDAQ:OPRXOptimizeRx Corporation
19/08/202222h46Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:OPRXOptimizeRx Corporation
10/08/202214h05TipRanksB.Riley Financial Sticks to Their Buy Rating for OptimizeRx (OPRX)NASDAQ:OPRXOptimizeRx Corporation
10/08/202214h01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:OPRXOptimizeRx Corporation
25/07/202216h13TipRanksDown More Than 50%: These 2 ‘Strong Buy’ Stocks Are Trading at Rock-Bottom PricesNASDAQ:OPRXOptimizeRx Corporation
20/07/202213h25TipRanksB.Riley Financial Remains a Buy on OptimizeRx (OPRX)NASDAQ:OPRXOptimizeRx Corporation
 Showing the most relevant articles for your search:NASDAQ:OPRX

Dernières Valeurs Consultées

EU
PX1
CAC 40
EU
RNO
Renault
FTSE
UKX
FTSE 100
EU
SGO
Cie de SaintGobain
EU
GLE
Societe Generale
EU
VK
Vallourec
NYSE
NKE
Nike
NYSE
DIS
Walt Disney
EU
BEL20
Bel 20
EU
ACA
Credit Agricole
NYSE
MCD
McDonalds
NASDAQ
AAPL
Apple
EU
PX4
SBF 120
USI
USTECH100
US Tech 100
COIN
ETHUSD
Ethereum
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés